We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this ...

FRIDAY, April 25, 2025 (HealthDay News) -- On Tuesday, the U.S. Department of Health and Human Services announced that the ...

Company aims to develop a bird flu vaccine with rapid mass production and variant responsiveness. SK bioscience and KDCA join ...

Novavax faces uncertainty as FDA requests a new clinical trial for its COVID-19 vaccine, the last protein-based option in the ...

The nasal vaccine, tested on animals since 2021, may offer a new tool in fighting COVID-19 with a non-invasive, ...

Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

Clinical trials for the NIH's new universal flu vaccine are anticipated by 2026, with FDA approval by 2029. Other viruses ...

Avian influenza A(H5N1), commonly known as ... Moderna is currently in the very early stages of testing a bird flu vaccine using the same mRNA technology that allowed for rapid development and ...

mRNA vaccines offer clear advantages and disadvantages ... candidates for seasonal influenza and COVID-19 in Phase 2 and avian influenza in Phase 1 clinical development. Sanofi is developing ...

The company made a name for itself by quickly developing an effective coronavirus vaccine when the world needed ... While we ...

Per the Post, which first reported the story, “‘All new vaccines will undergo safety testing in placebo-controlled trials ...